Showing 34,667 results

Filters
New & experimental HIV treatments

White blood cell changes on islatravir do not lead to a higher risk of infections

News
28 February 2023
Ethnic & cultural minorities

Health & Power: February 2023 Video

February 2023
Coronavirus

Study Bite: Excess COVID-19 Deaths Estimated Among U.S. PLWH

Editor's pick
TheBodyPro
27 February 2023
The search for an HIV prevention vaccine

Q&A: An optimistic view of a ‘failed’ HIV vaccine trial

Editor's pick
Healio
27 February 2023
Sexually transmitted infections epidemiology

Extensively Drug-Resistant Shigellosis on the Rise in the U.S.

Editor's pick
MedPage Today
27 February 2023
Injectable & long-acting PrEP

Long-Acting CAB for PrEP Acceptable, Safe in Adolescent Female Africans

Editor's pick
NATAP
27 February 2023
Treatment outcomes & life expectancy

Rates of Key Death Causes With HIV Falling in Europe/America

Editor's pick
NATAP
27 February 2023
PrEP science

HIV infections acquired while on injectable PrEP may take a very long time to be spotted

News
27 February 2023
Vaginal rings & topical PrEP

Promising new PrEP method undergoes first safety study for anal sex

News
24 February 2023
Mental & emotional health problems

Anxiety, Depression, and Different Types of MI in people living with HIV

Editor's pick
TheBodyPro
24 February 2023
Mental & emotional health & wellbeing

Combinations containing TAF and cobicistat linked to physical depression symptoms in women with HIV

News
23 February 2023

КРОИ 2023: Ежеквартальное введение инъекционного ДКП-препарата может быть эффективным у женщин, Четверг, 23 февраля 2023 г.

February 2023

CROI 2023: Des injections trimestrielles de PrEP peuvent être efficaces chez les femmes, Jeudi 23 février 2023

February 2023

CROI 2023: PrEP, per le donne potrebbe essere efficace anche una sola iniezione trimestrale, giovedì 23 febbraio 2023

February 2023

CROI 2023: Las inyecciones trimestrales de PrEP pueden ser eficaces para las mujeres, Jueves, 23 de febrero de 2023

February 2023

CROI 2023: Injeções trimestrais de PrEP podem ser eficazes para mulheres, Quinta-feira, 23 de fevereiro de 2023

February 2023
Combatting stigma

Silence Will Not Save You

Editor's pick
TheBody
23 February 2023
Injectable & long-acting HIV treatment

CROI 2023: Lenacapavir and two broadly neutralising antibodies for treatment Video

February 2023
Resistance

Treating HIV? Memorize These 12 HIV Resistance Mutations. Yes, Really.

Editor's pick
TheBodyPro
23 February 2023
Hepatitis B

ALLIANCE trial shows positive HIV/HBV coinfection treatment data

Editor's pick
Healio
23 February 2023
HIV in the arts & media

‘The First Fallen’ Review: A Remembrance of Those Passed

Editor's pick
The New York Times
23 February 2023
Injectable & long-acting PrEP

Modeling study shows that long-acting injectable cabotegravir has the potential to significantly reduce new HIV infections

Editor's pick
Clinton Health Access Initiative
23 February 2023
The search for an HIV prevention vaccine

A HIV Vaccine Candidate Demonstrates Its Safety and Capacity to Induce an Immune Response

Editor's pick
ANRS
23 February 2023
New & experimental HIV treatments

Merck Opens Enrollment in New Phase 3 Clinical Trials with Investigational Once-Daily Islatravir in Combination with Doravirine for Treatment of HIV-1 Infection

Editor's pick
Merck press release
23 February 2023